Nursing care of children with leukemia Introduction Leukemia is cancer of the blood and develops in the bone marrow. The bone marrow is the soft, spongy center of the long bones that produces the three major blood cells: white blood cells to fight infection; red blood cells that carry oxygen; Platelets that help with blood clotting and stop bleeding. When a child has leukemia, the bone marrow, for an unknown reason, begins to make white blood cells that do not mature correctly, but continue to reproduce themselves. Normal, healthy cells only reproduce when there is enough space for them to fit. The body can regulate the production of cells by sending signals when to stop. With leukemia, these cells do not respond to the signals to stop and reproduce, regardless of space available. These abnormal cells reproduce very quickly and do not function as healthy white blood cells to help fight infection. When the immature white blood cells, called blasts, begin to crowd out other healthy cells in the bone marrow, the child experiences the symptoms of leukemia (i.e., infections, anemia, bleeding). Incidence of leukemia Leukemia is the most common form of cancer in childhood. 30 percent of childhood cancers are leukemia. Leukemia can occur at any age, although it is most commonly seen in children between 2 and 6 years of age. The disease occurs slightly more frequently in males than in females. Causes of leukemia in children The majority of childhood leukemia are acquired genetic diseases. exposure to certain viruses, environmental factors, chemical exposures, and various infections have been associated with damage to the immune system and thus leukemia. With the exception of specific genetic syndromes, little is known about the causes of childhood leukemia. Types of leukemia There are three main types of leukemia, including the following: Acute Lymphocytic Leukemia (ALL) Acute lymphocytic leukemia (ALL), also called lymphoblastic or lymphoid, accounts for about 75 to 80 percent of the childhood leukemias. In this form of the disease, the lymphocyte cell line is affected. . With acute lymphocytic leukemia, the bone marrow makes too many of these lymphocytes and they do not mature correctly. The lymphocytes overproduce, thus, crowding out other blood cells. Immature blood cells (blasts) do not work properly to fight infection. Acute leukemia can occur over a short period of days to weeks. Acute Myelogenous Leukemia (AML) Acute myelogenous leukemia (AML), also called granulocytic, myelocytic, myeloblastic, or myeloid, accounts for about 20 percent of the childhood leukemias. Acute myelogenous leukemia is a cancer of the blood in which too many granulocytes, a type of white blood cell, are produced in the marrow. crowding out other blood cells. Acute leukemia can occur over a short period of days to weeks. Children with certain genetic syndromes are at a higher risk of developing AML than other children. Chronic Myeloblastic Leukemia (CML) Chronic myeloblastic leukemia (CML) is uncommon in children. Chronic myeloblastic leukemia is cancer of the blood in which too many granulocytes, a type of white blood cell, are produced in the marrow. . The marrow continues to produce these abnormal cells which crowd out other healthy blood cells. Chronic myeloblastic leukemia can occur over a period of months or years. The type of leukemia is determined by where the cell is in the stage of development when it becomes malignant, or cancerous. The stem cell matures into either the lymphoid or myeloid cells. The lymphoid cells mature into either B-lymphocytes or T-lymphocytes. If the leukemia is among these cells, it is called acute lymphocytic leukemia (ALL).. The myeloid cells develop into platelets, red blood cells, and specialized white blood cells called neutrophils and macrophages. There are many classifications of AML. The type of leukemia is determined by the stage of development when the normal cells become leukemia cells. Symptoms of leukemia Because leukemia is cancer of the blood-forming tissue called the bone marrow, the initial symptoms are often related to irregular bone marrow function. Anemia Bleeding and / or Bruising Recurrent Infections Bone and Joint Pain Abdominal Distress Abdominal pain may also be a symptom of leukemia. Leukemia cells can collect in the kidney, liver, and spleen, causing enlargement of these organs. Pain in the abdomen may cause a child to have loss of appetite and weight loss. Swollen Lymph Nodes The child may also have swelling in the lymph nodes under the arms, in the groin, chest, and in the neck. Lymph nodes are responsible for filtering the blood. Leukemia cells may collect in the nodes, causing swelling. Difficulty Breathing (dyspnea) With T-cell ALL, these leukemia cells tend to clump together around the thymus. This mass of cells present in the middle of the chest can cause pain and difficulty breathing (dyspnea). Wheezing, coughing, and/or painful breathing requires immediate medical attention. With acute leukemia (ALL or AML), these symptoms may occur suddenly in a matter of days or weeks. With chronic leukemia (CML), these symptoms may develop slowly over months to years. Diagnosis of leukemia In addition to a complete medical history and physical examination, diagnostic procedures for leukemia may include: Bone marrow aspiration and biopsy - marrow may be removed by aspiration or a needle biopsy under local anesthesia. In aspiration biopsy, a fluid specimen is removed from the bone marrow. In a needle biopsy, marrow cells (not fluid) are removed. These methods are often used together. Complete blood count (CBC) Additional blood tests - may include blood chemistries, evaluation of liver and kidney functions, and genetic studies. Computerized tomography scan (Also called a CT or CAT scan.) Magnetic resonance imaging (MRI) X-ray Ultrasound Lymph node biopsy Spinal tap/lumbar punctures. Treatment for Leukemia Specific treatment for leukemia will be determined based on: child's age, overall health, and medical history the extent of the disease child's tolerance for certain medications, procedures, or therapies Expectations for the course of the disease Treatment usually begins by addressing the presenting symptoms such as anemia, bleeding, and/or infection. In addition, treatment for leukemia may include (alone or in combination) the following: Chemotherapy Intrathecal medications / chemotherapy (medications are inserted through a needle into the spinal cord into the area called the subarachnoid space) Radiation therapy Bone marrow transplantation Biological therapy Medications (to prevent or treat damage to other systems of the body caused by leukemia treatment) Medications (for nausea and side effects of treatment) Blood transfusions (red blood cells, platelets) Antibiotics (to prevent/treat infections) Continuous follow-up care (to determine response to treatment, detect recurrent disease, and manage late effects of treatment) Stages of leukemia treatment There are various stages in the treatment of leukemia, including: Induction - a combination of chemotherapy and/or radiation and medications given to stop the process of abnormal cells being made in the bone marrow. Remission is the goal in this stage of treatment. Remission means the leukemia cells are no longer being made. This phase may last approximately one month and can be repeated if the goal is not achieved.the drugs used for ALL are corticosteroids especially prednisone,vincristine,L-asparaginase with without doxorubicin.drug for AML includes doxorubicin or daunomycin and cytosine arabinoside .this period last for 4-6 weeks Intensification - continued treatment even though leukemia cells may not be visible. The leukemia cells may not be visible in a blood test or bone marrow examination, but it is possible that the cells are still present in the body. Intrathecal and systemic chemotherapy with Lasparaginase.methotrexate,cytarabine,vincristine and mercaptopurine over a period of several months. Maintenance - the stage that maintains leukemia-free bone marrow by continuing less intense chemotherapy for a longer duration. This phase can last months to several years.combined drug regimen include daily mercaptopurine,weekly methotrexate,and periodic intrathecal therapy. Regular visits to child's physician are required in order to determine response to treatment, detect any recurrent disease, and manage any side effects of the treatment. Relapse - may occur even with aggressive therapy. Relapse is when the bone marrow begins making abnormal cells again. Relapse can occur during any of the stages of treatment, or may occur months or years after treatment has ended.Therapy includes reinduction with prednisone and vincristine along with other drugs. Prognosis Depends on: The extent of the disease Disease response to treatment Genetics Age and overall health of the child child's tolerance of specific medications, procedures, or therapies New developments in treatment